share_log

誉衡药业(002437.SZ):目前无分拆港股上市计划

Harbin Gloria Pharmaceuticals (002437.SZ): Currently, there are no plans for a spin-off listing on the Hong Kong stock market.

Gelonghui Finance ·  Dec 19 16:05

On December 19, Gelonghui reported that Harbin Gloria Pharmaceuticals (002437.SZ) stated on the investor interaction platform that the company's products, Annao Pills/Tablets, are unique essential pharmaceutical varieties of Traditional Chinese Medicine. The company will increase investment to enhance product competitiveness through improving product qualifications, increasing clinical medication guidelines, and professional academic promotions. Additionally, the company will actively seek differentiated products through independent research and development, cooperative development, mergers and acquisitions, and introduction, continuously enriching the company's product pipeline with high-end generic drugs and distinctive Chinese Patent Medicines, which have technical barriers. The company currently has no plans for a separate listing on the Hong Kong Stock Exchange.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment